tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

BMYBristol Myers Squibb

Health care · Pharmaceuticals · NYSE
Compare with peers → Embed
CEO pay, fiscal year to Dec 31, 2025

Dr. Chris Boerner was paid $21.9M as reported, $16.9M at the share price

Proxy (DEF 14A)
CEO pay, as reported
$21.9M
salary, bonus and awards at grant value
CEO pay, actually paid
$16.9M
awards valued at the share price
$100 in the shares became
$105
peer group: $198
CEO pay, 5 years
$108.6M
up 11% while net income rose 1%
Pay versus performance

Pay against results, year by year

Proxy, filed Mar 25, 2026
Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) Other executives, average$100 becamePeer groupNet income Total revenues
Dec 31, 2025Dr. Chris Boerner $21.9M$16.9M $9.2M $105$198 $7.1B $48.2B
Dec 31, 2024Dr. Chris Boerner $18.8M$21.2M $7.7M $105$154 -$8.9B $48.3B
Dec 31, 2023Dr. Giovanni Caforio $28.1M-$6.5M $5.9M $91$142 $8.0B $45.0B
Dec 31, 2022Dr. Giovanni Caforio $20.1M$35.1M $7.0M $123$139 $6.3B $46.2B
Dec 31, 2021Dr. Giovanni Caforio $19.8M$16.5M $7.1M $103$126 $7.0B $46.4B

Pay versus performance table of the proxy statement (DEF 14A) filed Mar 25, 2026, as tagged by the company in XBRL. Open the proxy ↗

Next Crypto holdings →